LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 40

Search options

  1. Article ; Online: Pulmonary nontuberculous mycobacterial infections and environmental factors: A review of the literature.

    Gardini, Giulia / Ori, Margherita / Codecasa, Luigi Ruffo / Matteelli, Alberto

    Respiratory medicine

    2021  Volume 189, Page(s) 106660

    Abstract: Background: Pulmonary nontuberculous mycobacterial (pNTM) infection is mainly acquired through the inhalation of bioaerosols. Nevertheless, behavioural restrictions are rarely given by clinicians to susceptible populations, in part because the available ...

    Abstract Background: Pulmonary nontuberculous mycobacterial (pNTM) infection is mainly acquired through the inhalation of bioaerosols. Nevertheless, behavioural restrictions are rarely given by clinicians to susceptible populations, in part because the available guidelines for pNTM management emphasize more diagnosis and treatment than prevention. Aim of this review is to clarify if pNTM prevention should routinely include recommendations about risk reducing behaviors.
    Methods: We used PubMed as biomedical database. We limited our search to the publication period 2000 to 2020 with selected keyword combinations including "nontuberculous mycobacteria", "water", "soil", and "exposure". Titles and abstract of selected articles were systematically screened. Articles were included in the analysis if they were published under free access through the digital library of the University of Brescia (Italy), and provided full text either in English, French, German or Italian. Articles were excluded if the topic was beyond the aim of our study. Finally, we selected 20 articles.
    Results: Studies disagree in identifying the type of aerosol posing the highest risk for the development of pNTM infection. In the retrieved publications the colonization of household niches has been associated with a higher risk of pNTM disease, such as in the exposure to shower aerosols. Considering the non-household settings, the exposure to aerosols in indoor swimming and the higher soil exposure (>2 h/week) seem to correlate with a higher risk to develop pNTM disease. According to our findings, randomized behavioural intervention studies are missing.
    Conclusions: Stringent scientific evidence is missing to formulate recommendations on behavioural risk reduction for pNTM.
    MeSH term(s) Air Microbiology ; Disease Susceptibility ; Environmental Exposure ; Humans ; Lung Diseases/microbiology ; Lung Diseases/prevention & control ; Mycobacterium Infections, Nontuberculous/microbiology ; Mycobacterium Infections, Nontuberculous/prevention & control ; Risk Factors ; Soil Microbiology
    Language English
    Publishing date 2021-10-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2021.106660
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis.

    Suska, Kseniia / Amati, Francesco / Sotgiu, Giovanni / Gramegna, Andrea / Mantero, Marco / Ori, Margherita / Ferrarese, Maurizio / Codecasa, Luigi Ruffo / Stainer, Anna / Blasi, Francesco / Aliberti, Stefano

    ERJ open research

    2022  Volume 8, Issue 4

    Abstract: Background: Although interest in nontuberculous mycobacteria (NTM) infection has increased in the last decades, published data vary according to different geographical areas, diagnostic facilities and quality of study design. This study aims at ... ...

    Abstract Background: Although interest in nontuberculous mycobacteria (NTM) infection has increased in the last decades, published data vary according to different geographical areas, diagnostic facilities and quality of study design. This study aims at assessing both prevalence and incidence of NTM infection and NTM pulmonary disease (NTM-PD) among adults with bronchiectasis, to describe patients' characteristics, therapeutic options and clinical outcomes.
    Methods: Bronchiectasis adults who had been tested for NTM were enrolled at the Bronchiectasis Program of the Policlinico Hospital in Milan, Italy, from 2016 to 2018.
    Results: Among the 373 patients enrolled, 26.1% had at least one respiratory sample positive for NTM and 12.6% reached a diagnosis of NTM-PD. Incidence rates for NTM infection and NTM-PD were 13 (95% CI 10-16) and 4 (95% CI 2-6) per 100 person-years, respectively. The most prevalent NTM species causing NTM-PD were
    Conclusions: NTM infection is frequent in bronchiectasis patients and the presence of NTM-PD is relevant. The low success rate of NTM-PD treatment in bronchiectasis patients requires a call to action to identify new treatment modalities and new drugs to improve patients' outcomes.
    Language English
    Publishing date 2022-12-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00060-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Celebrating World Tuberculosis Day at the time of COVID-19.

    Alagna, Riccardo / Besozzi, Giorgio / Codecasa, Luigi Ruffo / Gori, Andrea / Migliori, Giovanni Battista / Raviglione, Mario / Cirillo, Daniela Maria

    The European respiratory journal

    2020  Volume 55, Issue 4

    MeSH term(s) Anniversaries and Special Events ; Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; Tuberculosis ; World Health Organization
    Keywords covid19
    Language English
    Publishing date 2020-04-23
    Publishing country England
    Document type Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00650-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom.

    García-García, José-María / Blanc, François-Xavier / Buonsenso, Danilo / Centis, Rosella / Codecasa, Luigi Ruffo / D'Ambrosio, Lia / Goletti, Delia / Gualano, Gina / Kunst, Heinke / Pontali, Emanuele / Tadolini, Marina / Tiberi, Simon / Ong, Catherine W M / Sotgiu, Giovanni / Migliori, Giovanni Battista

    Archivos de bronconeumologia

    2022  Volume 58, Issue 11, Page(s) 783–785

    MeSH term(s) Humans ; Spain/epidemiology ; COVID-19 ; Italy/epidemiology ; France/epidemiology ; United Kingdom ; Germany
    Language Spanish
    Publishing date 2022-08-13
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2022.07.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens: A Two-Decade Experience in Milan, Italy.

    Villa, Simone / Ferrarese, Maurizio / Sotgiu, Giovanni / Castellotti, Paola Francesca / Saderi, Laura / Grecchi, Cecilia / Saporiti, Matteo / Raviglione, Mario / Codecasa, Luigi Ruffo

    Journal of clinical medicine

    2019  Volume 9, Issue 1

    Abstract: To tackle the tuberculosis (TB) epidemic, in 2014 the World Health Organization launched the End TB Strategy, which includes action to prevent latent TB infection (LTBI) reactivation. Available preventive treatments (PT) are based on either isoniazid ( ... ...

    Abstract To tackle the tuberculosis (TB) epidemic, in 2014 the World Health Organization launched the End TB Strategy, which includes action to prevent latent TB infection (LTBI) reactivation. Available preventive treatments (PT) are based on either isoniazid (INH) alone or rifampicin (RIF)-containing regimens. This study aims to assess and compare PT completion rates, the occurrence of adverse events, and the time of dropout among those receiving INH-alone or RIF-containing regimens at Villa Marelli Institute, Milan, Italy, covering the period from 1992 to 2018. A total of 19670 subjects, belonging to various risk groups-mainly young (median age of 29 years), foreign-born (73.3%), and males (58.8%)-with presumed LTBI were prescribed PT (79.3% INH-alone and 20.7% RIF-containing regimens). The treatment completion rate was 79.4% on average, with higher rates among those receiving RIF-containing regimens (85.6%) compared to those that were prescribed INH-alone (77.8%) (
    Language English
    Publishing date 2019-12-31
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm9010101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.

    Villa, Simone / Tagliani, Elisa / Borroni, Emanuele / Castellotti, Paola Francesca / Ferrarese, Maurizio / Ghodousi, Arash / Lamberti, Anna / Senatore, Sabrina / Faccini, Marino / Cirillo, Daniela Maria / Codecasa, Luigi Ruffo

    The European respiratory journal

    2021  Volume 58, Issue 3

    MeSH term(s) Antitubercular Agents/therapeutic use ; Disease Outbreaks ; Extensively Drug-Resistant Tuberculosis/drug therapy ; Extensively Drug-Resistant Tuberculosis/epidemiology ; Humans ; Italy/epidemiology ; Mycobacterium tuberculosis ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology
    Chemical Substances Antitubercular Agents
    Language English
    Publishing date 2021-09-16
    Publishing country England
    Document type Letter
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00839-2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: From the past, a long way to future challenges for a greater control of tuberculosis.

    Villa, Simone / Riccardi, Niccolò / Canetti, Diana / Alagna, Riccardo / Castellotti, Paola / Ferrarese, Maurizio / Cirillo, Daniela / Barberis, Ilaria / Bragazzi, Nicola Luigi / Gazzaniga, Valentina / Ricucci, Valentina / Codecasa, Luigi Ruffo / Besozzi, Giorgio / Martini, Mariano

    Tuberculosis (Edinburgh, Scotland)

    2020  Volume 123, Page(s) 101948

    Abstract: Tuberculosis (TB) and humans have coexisted for more than 40,000 years; however TB remains a global threat to human kind. The international community has developed new tools for early detection, but TB strains evolved acquiring resistance to first-line ... ...

    Abstract Tuberculosis (TB) and humans have coexisted for more than 40,000 years; however TB remains a global threat to human kind. The international community has developed new tools for early detection, but TB strains evolved acquiring resistance to first-line therapeutic drugs with increasing treatment challenges. Furthermore, TB has formed also an alliance with human immunodeficiency virus; in this way the poorest populations are most affected. The current vaccine planning activity includes 14 new vaccines against TB (11 of those in the phaseII/III) developed with different techniques. Now, more than ever, new anti-TB drugs and new anti-TB regimens are urgently required as well as universal health care and social protection in order to tackle down both hard to treat TB and the social determinants of TB. Coordinated actions and sharing of information are needed to aspire everywhere to the best clinical practices and improve quality of life of patients and their families.
    MeSH term(s) Antitubercular Agents/therapeutic use ; Diffusion of Innovation ; Drug Development/trends ; Forecasting ; Host-Pathogen Interactions ; Humans ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/immunology ; Mycobacterium tuberculosis/pathogenicity ; Tuberculosis/drug therapy ; Tuberculosis/immunology ; Tuberculosis/microbiology ; Tuberculosis Vaccines/therapeutic use
    Chemical Substances Antitubercular Agents ; Tuberculosis Vaccines
    Language English
    Publishing date 2020-06-06
    Publishing country Scotland
    Document type Journal Article
    ZDB-ID 2046804-0
    ISSN 1873-281X ; 1472-9792
    ISSN (online) 1873-281X
    ISSN 1472-9792
    DOI 10.1016/j.tube.2020.101948
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.

    Torre, Alessandro / Aliberti, Stefano / Castellotti, Paola Francesca / Cirillo, Daniela Maria / Grisolia, Antonella / Mangioni, Davide / Marchetti, Giulia / Rossotti, Roberto / Santus, Pierachille / Besozzi, Giorgio / Villa, Simone / Codecasa, Luigi Ruffo

    Respiratory medicine

    2020  Volume 175, Page(s) 106204

    Abstract: COVID-19, the novel coronavirus pandemic, has already spread around the globe affecting more than 18 million people. As previously observed with other coronaviruses, SARS-CoV-2 deeply dysregulate the immune system eliciting respiratory failure and a ... ...

    Abstract COVID-19, the novel coronavirus pandemic, has already spread around the globe affecting more than 18 million people. As previously observed with other coronaviruses, SARS-CoV-2 deeply dysregulate the immune system eliciting respiratory failure and a state of systemic hyperinflammation in severely ill individuals. Immunotherapy is often used to downgrade the detrimental effects of the disease sustained by high-level of cytokines. Those treatments, however, are known to undermine patients' ability to contain tuberculosis (TB) infection. This study aims to describe interferon-γ release assay (IGRA) results in severe COVID-19 patients eligible for immunosuppressive treatment. Aggregate data were gathered from five hospitals in Milan, Italy, from March 1 to May 15, 2020 and retrospectively analyses. Results were summarized using absolute frequencies and percentages and compared using a two-sided Chi-squared test. Overall, 462 COVID-19 patients were eligible for immunosuppressive therapy, among which 335 were tested using IGRA testing. More than one-third of them (122/335; 36.4%) had an indeterminate IGRA result because of insufficient immune response to mitogen control, 19 (5.7%) tested positive and 194 (57.9) negative. The majority of patients with lymphocytopenia (i.e., total lymphocyte count [TLC] below 1000 cells/mm
    MeSH term(s) Antibodies, Monoclonal, Humanized/therapeutic use ; Antirheumatic Agents/therapeutic use ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/therapy ; COVID-19/virology ; Female ; Humans ; Immunity/physiology ; Immunosuppression Therapy/methods ; Interferon-gamma Release Tests/methods ; Interferon-gamma Release Tests/statistics & numerical data ; Interleukin 1 Receptor Antagonist Protein/therapeutic use ; Italy/epidemiology ; Latent Tuberculosis/diagnosis ; Latent Tuberculosis/epidemiology ; Latent Tuberculosis/immunology ; Latent Tuberculosis/prevention & control ; Lymphopenia/immunology ; Male ; Retrospective Studies ; SARS-CoV-2/genetics ; Severity of Illness Index
    Chemical Substances Antibodies, Monoclonal, Humanized ; Antirheumatic Agents ; Interleukin 1 Receptor Antagonist Protein ; tocilizumab (I031V2H011)
    Keywords covid19
    Language English
    Publishing date 2020-11-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2020.106204
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.

    Villa, Simone / Codecasa, Luigi Ruffo / Faccini, Marino / Pontello, Mirella Maria / Ferrarese, Maurizio / Castellotti, Paola Francesca / Senatore, Sabrina / Lamberti, Anna / Mazzola, Ester / Perno, Carlo Federico / Campisi, Daniela / Saporiti, Matteo / Raviglione, Mario Carlo

    The European respiratory journal

    2020  Volume 55, Issue 4

    MeSH term(s) Humans ; Latent Tuberculosis ; Mass Screening ; Refugees ; Research ; Tuberculosis
    Language English
    Publishing date 2020-04-30
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00052-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study.

    Aliberti, Stefano / Sotgiu, Giovanni / Castellotti, Paola / Ferrarese, Maurizio / Pancini, Lisa / Pasat, Ana / Vanoni, Nicolò / Spotti, Maura / Mazzola, Ester / Gramegna, Andrea / Saderi, Laura / Perno, Carlo Federico / van Ingen, Jakko / Codecasa, Luigi Ruffo / Blasi, Francesco

    Respiratory medicine

    2020  Volume 164, Page(s) 105899

    Abstract: Outcome recognition is a crucial step in the management of non-tuberculous mycobacteria lung disease (NTM-LD). In order to explore NTM-LD outcomes in a real-life setting, an observational, retrospective study enrolling consecutive adults who received ... ...

    Abstract Outcome recognition is a crucial step in the management of non-tuberculous mycobacteria lung disease (NTM-LD). In order to explore NTM-LD outcomes in a real-life setting, an observational, retrospective study enrolling consecutive adults who received treatment for NTM-LD in Milan, Italy, from 2007 to 2017 was conducted. Among 170 patients (68.2% females; median age: 68 years), NTM-LD was mainly due to M. avium complex (MAC) (71.2%), M. kansasii (9.4%) and M. xenopi (7.1%). Along a median follow-up of 31 months, adverse events occurred in 37.6% of the patients. Treatment outcomes of the entire study population included an unsuccessful outcome in 35.3% of the patients, including treatment halted in 13.5%, recurrence in 11.2%, re-infection in 5.3%, treatment failure in 4.1% and relapse in 1.2%. The main reason for treatment halted was drug intolerance. No differences were detected between patients with MAC-LD vs. those with other NTM-LD in terms of unsuccessful outcome in general (35.5% vs. 34.7%). A significantly higher prevalence of patients who underwent treatment halted was found in patients with NTM-LD other than MAC in comparison to patients with MAC-LD (22.4% vs. 9.9%, p = 0.030). One third of adults undergoing treatment for a NTM-LD experiences an unsuccessful outcome with adverse events and treatment discontinuation being major challenges in patients' management.
    MeSH term(s) Aged ; Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Comorbidity ; Female ; Follow-Up Studies ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Mycobacterium Infections, Nontuberculous/drug therapy ; Mycobacterium Infections, Nontuberculous/epidemiology ; Mycobacterium avium Complex ; Mycobacterium avium-intracellulare Infection/drug therapy ; Mycobacterium avium-intracellulare Infection/epidemiology ; Mycobacterium kansasii ; Mycobacterium xenopi ; Retrospective Studies ; Time Factors ; Treatment Outcome
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-02-14
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2020.105899
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top